Evaluation of second line and subsequent targeted therapies in metastatic renal cell cancer (mRCC) patients treated with first line cediranib Academic Article uri icon

authors

  • Richter, S
  • Seah, J-A
  • Pond, GR
  • Gan, HK
  • Mackenzie, MJ
  • Hotte, SJ
  • Mukherjee, SD
  • Murray, N
  • Kollmannsberger, C
  • Heng, D
  • Haider, MA
  • Halford, R
  • Ivy, SP
  • Moore, MJ
  • Sridhar, SS

publication date

  • 2014